Article info

Original research
Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

Authors

  • Aanika Balaji Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USAThe Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Melinda Hsu Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USAThe Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Cheng Ting Lin Radiology, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Josephine Feliciano Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USAThe Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Kristen Marrone Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USAThe Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Julie R Brahmer Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USAThe Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Patrick M Forde Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USAThe Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Christine Hann Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USAThe Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Lei Zheng Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USAThe Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Valerie Lee Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USAThe Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Peter B Illei Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USADivision of Pathology, Johns Hopkins University, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  • Sonye K Danoff Pulmonology and Critical Care Medicine, Johns Hopkins Medicine School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Karthik Suresh Pulmonology and Critical Care Medicine, Johns Hopkins Medicine School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Jarushka Naidoo Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USAThe Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Jarushka Naidoo; jnaidoo1{at}jhmi.edu
View Full Text

Citation

Balaji A, Hsu M, Lin CT, et al
Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

Publication history

  • Accepted November 29, 2020
  • First published January 7, 2021.
Online issue publication 
January 07, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.